FDA Adverse Event Injury Summary report: N

ALTIS SINGLE INCISION SLING SYSTEM

MDR report key: 16018426 · Received December 20, 2022

Report

Report Number
2125050-2022-01418
Event Type
Injury
Date Received
December 20, 2022
Date of Event
April 26, 2022
Report Date
December 9, 2022
Manufacturer
COLOPLAST A/S
Product Code
PAH
UDI-DI
05708932467407
PMA / PMN Number
K121562
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

CITATION: MELON J, KARJALAINEN PK, MCGANNON C, LEE JK, ROSAMILIA A. MEDIUM-TERM CLINICAL EFFICACY AND SAFETY OF SINGLE INCISION AND MODIFIED TRANS-OBTURATOR MID-URETHRAL SLINGS FOR FEMALE STRESS URINARY INCONTINENCE. GOCM 2 (2022) 57-62. HTTPS://DOI.ORG/10.1016/J.GOCM.2022.04.004. SHOULD ADDITIONAL INFORMATION PROMPT US TO ALTER OR SUPPLEMENT ANY INFORMATION OR CONCLUSIONS CONTAINED IN THIS REPORT, A FOLLOW-UP REPORT WILL BE SUBMITTED.

Description of Event or Problem · 0

ACCORDING TO THE AVAILABLE INFORMATION, OF THE 60 WOMEN IMPLANTED WITH ALTIS BETWEEN 2012 AND 2018 WHO WERE AVAILABLE FOR FINAL ANALYSIS RELATED TO THIS STUDY: -TWO SLINGS WERE REMOVED OR "DIVIDED"; ONE WAS "DIVIDED" FIVE MONTHS POST OP FOR CHRONIC LOW-GRADE VOIDING DYSFUNCTION FOLLOWING EPISODIC CLEAN INTERMITTENT SELF-CATHETERIZATION. -ONE SLING WAS LOOSENED EARLY FOR VOIDING DYSFUNCTION. -TWO PATIENTS RECEIVED REPEATED SLINGS; ONE SLING HAD BEEN REMOVED A WEEK POST OP FOR SEVERE GROIN PAIN. A RETROPUBIC SLING WAS PLACED AT THAT TIME. -EARLY GROIN OR VAGINAL PAIN LASTING UP TO THREE MONTHS WAS REPORTED AS HIGHER IN THE ALTIS GROUP. IN THE SINGLE-INCISION-SLING GROUP, ALL PAIN WAS REPORTED AS RESOLVED BEFORE THREE MONTHS, EXCEPT FOR THREE ALTIS PATIENTS WHO REPORTED RESOLUTION AT 3, 6, AND 12 MONTHS RESPECTIVELY, WITH SIMPLE ANALGESIA AND PHYSIOTHERAPY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
447004 ALTIS SINGLE INCISION SLING SYSTEM SURGICAL MESH PAH COLOPLAST A/S 5196502400 05708932467407

Patients

Seq Age Sex Outcome Treatment
1 55 YR Female Required Intervention